Senior Vice President and President
Kevin Ballinger is Senior Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders. Ballinger has more than 17 years of interventional cardiology experience. Prior to his current role, he held a variety of engineering and general management positions within Boston Scientific’s Interventional Cardiology business unit, including overseeing the development of the company’s first drug-eluting stents. Ballinger earned a B.S. in Mechanical Engineering from Michigan Tech University and an MBA from the University of Minnesota.